Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1987 Nov;55(11):2574–2578. doi: 10.1128/iai.55.11.2574-2578.1987

Restoration of normal febrile response to endotoxin in pyrogen-tolerant rabbits by injection with human beta interferon.

H Kawasaki 1, M Moriyama 1, Y Ohtani 1, M Naitoh 1, H Nariuchi 1, A Tanaka 1
PMCID: PMC259944  PMID: 3499395

Abstract

Early-phase pyrogen tolerance was induced in rabbits by two consecutive daily injections of 125 ng of endotoxin per kg of body weight. The second injection of the same dose of endotoxin evoked only a monophasic fever with a peak response 1.5 h after the injection; no second peak was observed. The rabbits were released from the tolerance to develop a typical biphasic fever by an injection of 125 ng of endotoxin along with human beta interferon (HuIFN-beta), although the tolerance-inducing amount of endotoxin alone could not. The profile of the febrile response of tolerant rabbits injected with both endotoxin and HuIFN-beta could not be distinguished from that of normal rabbits. There was no essential difference between natural and recombinant HuIFN-beta in breaking tolerance. Heat-stable (70 degrees C, 30 min) endogenous pyrogen or tumor necrosis factor was increased significantly in concentration in the serum of tolerance-broken rabbits. These results suggest that HuIFN-beta stimulates the production of tumor necrosis factor in tolerant rabbits to elicit the second peak of febrile response.

Full text

PDF
2574

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Armstrong J. A. Semi-micro, dye-binding assay for rabbit interferon. Appl Microbiol. 1971 Apr;21(4):723–725. doi: 10.1128/am.21.4.723-725.1971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Beutler B., Cerami A. Cachectin and tumour necrosis factor as two sides of the same biological coin. Nature. 1986 Apr 17;320(6063):584–588. doi: 10.1038/320584a0. [DOI] [PubMed] [Google Scholar]
  3. Beutler B., Krochin N., Milsark I. W., Luedke C., Cerami A. Control of cachectin (tumor necrosis factor) synthesis: mechanisms of endotoxin resistance. Science. 1986 May 23;232(4753):977–980. doi: 10.1126/science.3754653. [DOI] [PubMed] [Google Scholar]
  4. Desmyter J., Rawls W. E., Melnick J. L. A human interferon that crosses the species line. Proc Natl Acad Sci U S A. 1968 Jan;59(1):69–76. doi: 10.1073/pnas.59.1.69. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Dinarello C. A., Bernheim H. A., Duff G. W., Le H. V., Nagabhushan T. L., Hamilton N. C., Coceani F. Mechanisms of fever induced by recombinant human interferon. J Clin Invest. 1984 Sep;74(3):906–913. doi: 10.1172/JCI111508. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Dinarello C. A., Bodel P. T., Atkins E. The role of the liver in the production of fever and in pyrogenic tolerance. Trans Assoc Am Physicians. 1968;81:334–344. [PubMed] [Google Scholar]
  7. Dinarello C. A., Cannon J. G., Mier J. W., Bernheim H. A., LoPreste G., Lynn D. L., Love R. N., Webb A. C., Auron P. E., Reuben R. C. Multiple biological activities of human recombinant interleukin 1. J Clin Invest. 1986 Jun;77(6):1734–1739. doi: 10.1172/JCI112495. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Dinarello C. A., Cannon J. G., Wolff S. M., Bernheim H. A., Beutler B., Cerami A., Figari I. S., Palladino M. A., Jr, O'Connor J. V. Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1. J Exp Med. 1986 Jun 1;163(6):1433–1450. doi: 10.1084/jem.163.6.1433. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Dinarello C. A., Wolff S. M. Molecular basis of fever in humans. Am J Med. 1982 May;72(5):799–819. doi: 10.1016/0002-9343(82)90548-4. [DOI] [PubMed] [Google Scholar]
  10. EICHENBERGER E., SCHMIDHAUSER-KOPP M., HURNI H., FRICSAY M., WESTPHAL O. Biologische Wirkungen eines hochgereinigten Pyrogens (Lipopolysaccharids) aus Salmonella abortus equi. Schweiz Med Wochenschr. 1955 Dec 3;85(49):1190–contd. [PubMed] [Google Scholar]
  11. Gomi K., Morimoto M., Nakamizo N. Growth-inhibitory activity of recombinant human interferon-beta against cultured human cells. Gan. 1983 Oct;74(5):737–742. [PubMed] [Google Scholar]
  12. Haranaka K., Satomi N., Sakurai A., Nariuchi H. Purification and partial amino acid sequence of rabbit tumor necrosis factor. Int J Cancer. 1985 Sep 15;36(3):395–400. [PubMed] [Google Scholar]
  13. Hashimoto H., Shibukawa N., Kojima Y. The mode of production of endotoxin-induced interferon in rabbit lymphoid cell cultures. II. Priming effect of interferon on apparently noninducible cells. Microbiol Immunol. 1979;23(10):1033–1036. doi: 10.1111/j.1348-0421.1979.tb00533.x. [DOI] [PubMed] [Google Scholar]
  14. Ho M., Breinig M. C. Preparation and characterization of rabbit interferon. Methods Enzymol. 1981;78(Pt A):131–138. doi: 10.1016/0076-6879(81)78106-0. [DOI] [PubMed] [Google Scholar]
  15. Kawasaki H., Moriyama M., Tanaka A. Augmentation of endotoxin fever by recombinant human beta interferon in rabbits. Infect Immun. 1987 May;55(5):1121–1125. doi: 10.1128/iai.55.5.1121-1125.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Levy-Koenig R. E., Mundy M. J., Paucker K. Immunology of interferons. I. Immune response to protective and nonprotective interferons. J Immunol. 1970 Apr;104(4):785–790. [PubMed] [Google Scholar]
  17. Paucker K., Dalton B. J., Ogburn C. A., Törmä E. Multiple active sites on human interferons. Proc Natl Acad Sci U S A. 1975 Nov;72(11):4587–4591. doi: 10.1073/pnas.72.11.4587. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Samanta H., Engel D. A., Chao H. M., Thakur A., García-Blanco M. A., Lengyel P. Interferons as gene activators. Cloning of the 5' terminus and the control segment of an interferon activated gene. J Biol Chem. 1986 Sep 5;261(25):11849–11858. [PubMed] [Google Scholar]
  19. Satoh M., Shimada Y., Inagawa H., Minagawa H., Kajikawa T., Oshima H., Abe S., Yamazaki M., Mizuno D. Priming effect of interferons and interleukin 2 on endogenous production of tumor necrosis factor in mice. Jpn J Cancer Res. 1986 Apr;77(4):342–344. [PubMed] [Google Scholar]
  20. Satoh Y. I., Kasama K., Kajita A., Shimizu H., Ida N. Different pharmacokinetics between natural and recombinant human interferon beta in rabbits. J Interferon Res. 1984 Summer;4(3):411–422. doi: 10.1089/jir.1984.4.411. [DOI] [PubMed] [Google Scholar]
  21. WOLFF S. M., MULHOLLAND J. H., WARD S. B. QUANTITATIVE ASPECTS OF THE PYROGENIC RESPONSE OF RABBITS TO ENDOTOXIN. J Lab Clin Med. 1965 Feb;65:268–275. [PubMed] [Google Scholar]
  22. Williamson B. D., Carswell E. A., Rubin B. Y., Prendergast J. S., Old L. J. Human tumor necrosis factor produced by human B-cell lines: synergistic cytotoxic interaction with human interferon. Proc Natl Acad Sci U S A. 1983 Sep;80(17):5397–5401. doi: 10.1073/pnas.80.17.5397. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES